Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity

The diabetes drug semaglutide, also known as Ozempic, has a positive effect for patients with chronic kidney damage and obesity. They

Navigating the Digital Front Door: Overcoming Friction in New Patient Registration

Scott Heatherly, VP of Sales at Amenities Health In today’s fast-paced digital age, traditional healthcare systems are under growing pressure to adapt their digital front-door

June 11, 2024

Regulatory RNA startup CAMP4 files for IPO as more biotechs line up listings

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 21, 2024

Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months – Biotech Investments

EQS-News: Marinomed Biotech AG / Key word(s): Agreement Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture

March 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.